Share-based Compensation - Hutchmed Share Option Scheme (Details) - HUTCHMED Share Option Scheme - shares |
6 Months Ended | |||
|---|---|---|---|---|
Apr. 24, 2015 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Share-based Compensation | ||||
| Expiry period | 10 years | |||
| Aggregate number of shares issuable | 43,616,756 | |||
| Outstanding share options | 23,093,022 | 25,674,233 | 29,640,273 | |
| Number of shares authorized but unissued | 627,664,880 | |||
| Maximum | ||||
| Share-based Compensation | ||||
| Expiry period | 10 years | |||
| Four-year awards | ||||
| Share-based Compensation | ||||
| Vesting period | 4 years | |||
| Vesting percentage upon first anniversary | 25.00% | |||
| Annual vesting percentage after the first anniversary | 25.00% |
| X | ||||||||||
- Definition Represents the percentage of stock awards vesting each year after the first anniversary of the vesting commencement date as defined in the grant letter. No definition available.
|
| X | ||||||||||
- Definition Represents the percentage of stock awards vesting upon first anniversary of the vesting commencement date as defined in the grant letter. No definition available.
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|